ev3 Inc. is a global leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment options, including the primary interventional technologies used today - plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. With a legacy in technology development and innovation, ev3 is helping endovascular specialists around the world perform more efficiently, effectively and predictably.
Investor Information
ev3 Fact Sheet
2009 Q1 (530KB PDF)
Annual Report
2008 Report
Medical Professionals
Informative information about all our products for medical professionals.
Patient Education
We care about patients and want to equip them with the knowledge they need.
Recent News
-
Jun 24, 2009
ev3 Closes Acquisition of Chestnut Medical Technologies, Inc.
-
Jun 02, 2009
ev3 Signs Agreement to Acquire Chestnut Medical Technologies, Inc.
-
May 07, 2009
ev3 Inc. to Present At the Banc of America Securities-Merrill Lynch 2009 Health Care Conference
Upcoming Events
Jul 09, 2009
Jul 27, 2009
Sep 22, 2009